Fundraising Fox
/Companies
Sign in

Centese

Omaha, US · Delaware corporation · 4 known investors

Find your way into Centese

Each arrow is one introduction. Sign up to fill in the first one.

210 people can intro you to Randy

Ask Brock Smith to introduce you to Randy Preston

You →Brock · together at Centese →Randy

Sign up to find every way you can get introduced to Centese

  • Your email: who you already know at Centese, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Centese team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions. The system is aimed at clinicians and ICU/critical care teams to support post-operative patient monitoring and recovery.

Digital HealthHardwareHealthtechMedical Devices

Founders & leadership

ELEvan Luxon
Evan LuxonCo-Founder
RPRandy Preston
Randy PrestonCEORandy Preston has spent two decades in medical device development, with cross-functional experience spanning product development, clinical work, program management, and market development. He is CEO of Centese, which develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery.
AC
Alan CheslerNamed on SEC filing

Board

RC
Radu CautisBoard directorGeneral Partner at Medical Technology Venture Partners
DB
Daniel BurnettBoard director
DG
Deepak GangaharBoard director

Investors · 4

New York Angelslisted by New York AngelsNew York · $100K – $1.5M

How we know: New York Angels's portfolio page · the VCSheet dataset · Not right? Tell us

Scientific Health Developmentlisted by Scientific Health DevelopmentDallas · $2M
Medical Technology Venture PartnersreportedSan Francisco

How we know: board seat on SEC Form D · finance.yahoo.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$15.9M disclosed across 3 rounds · 2023–2026

▶$250KraisedMay 2026 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Randy PrestonExecutive Officer, Director
  • Daniel BurnettDirector
  • Deepak GangaharDirector
  • Radu CautisDirector
Offering amount
$5M
Amount sold
$250K
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$525KraisedMay 2025 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Evan LuxonExecutive Officer, Director
  • Radu CautisDirector
  • Daniel BurnettDirector
  • Deepak GangaharDirector
Offering amount
$6.5M
Amount sold
$525K
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.1MraisedNov 2023 · 50 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan CheslerDirector
  • Dan BurnettDirector
  • Deepak GangaharDirector
  • Radu CautisDirector
  • Evan LuxonExecutive Officer, Director
Offering amount
$23.1M
Amount sold
$15.1M
Minimum investment
$1
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

TeleflexTeleflex is a medical device company. The available page content only references its receipt of an employer award for supporting veterans and does not describe its products or customers in detail.
Merit MedicalMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
BDBD is a global medical technology company developing devices, systems, and solutions for medication administration, diagnostics, connected care, biopharmaceutical manufacturing, and interventional procedures. The company serves healthcare providers, laboratories, and biopharmaceutical manufacturers across diagnostics, drug delivery, surgical care, and patient monitoring.

Companies working in the same space as Centese.

In the news

Centese, Inc. Secures Series B Funding and Strengthens Board With New Directorfinance.yahoo.com · Nov 2023Centese | Latest Newscentese.com · Sep 2021

Frequently asked questions

What does Centese do?
Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions. The system is aimed at clinicians and ICU/critical care teams to support post-operative patient monitoring and recovery.
Who founded Centese?
Centese was founded by Evan Luxon.
Who are Centese's investors?
Centese's investors include Invest Nebraska, New York Angels, Scientific Health Development, Medical Technology Venture Partners.
How much funding has Centese raised?
Centese has disclosed $15.9M raised across 3 rounds.
Where is Centese headquartered?
Centese is headquartered in Omaha, US.